Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis
RESEARCH HANDBOOK ON INTELLECTUAL PROPERTY LAW AND THE WTO, Carlos Correa, ed., Edward Elgar, 2009
22 Pages Posted: 20 May 2009
Date Written: May 20, 2009
Abstract
Compulsory licensure is one of the flexibilities retained under TRIPS to permit countries to support public health while granting pharmaceutical patents. The United States Government appears to take the position that compulsory licensure and other TRIPS flexibilities must be limited to certain infectious diseases, namely AIDS, tuberculosis, and malaria. These proposed limitations are not supported by the text of Articles 31 and 31bis of TRIPS or by the negotiating history of the Agreement. Introducing disease-based limitations would be unwise, as the developing world is undergoing a demographic transition, with increasing shares of its disease burden coming from non-infectious diseases. Public health calls for retaining TRIPS flexibilities in all categories of human need.
Keywords: compulsory license, TRIPS, pharmaceuticals, USTR, disease
JEL Classification: I18, K11, K33
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Intellectual Property Rights and North-South Trade
By Judith C. Chin and Gene M. Grossman
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Reaping What You Sow: An Empirical Analysis of International Patent Harmonization
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Patents, Appropriate Technology, and North-South Trade
By Ishac Diwan and Dani Rodrik
-
The North's Intellectual Property Rights Standard for the South?
By Edwin L.-c. Lai and Larry D. Qiu